Cargando…

Genetic mechanism for the loss of PRAME in B cell lymphomas

Detalles Bibliográficos
Autor principal:	Mraz, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282919/ https://www.ncbi.nlm.nih.gov/pubmed/35838053 http://dx.doi.org/10.1172/JCI160983

Ejemplares similares

Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply.
por: Takata, Katsuyoshi, et al.
Publicado: (2022)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies
por: Ondrisova, Laura, et al.
Publicado: (2020)

Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma
por: Takata, Katsuyoshi, et al.
Publicado: (2022)

Potential mechanisms of spontaneous regression in patients with B-cell lymphoma; the significance of co-stimulatory molecules in lymphoma cells
por: Komohara, Yoshihiro, et al.
Publicado: (2019)

The texture of collagen and immunoexpression of PRAME in dysplastic nevus syndrome lesions: relationship with melanoma()
por: Costa, Paula Regina Martins, et al.
Publicado: (2023)

Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators
por: Tanager, Kevin S., et al.
Publicado: (2021)

Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
por: Liu, Ying, et al.
Publicado: (2022)

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
por: Kizhakeyil, Atish, et al.
Publicado: (2021)

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022)

The Expansion of the PRAME Gene Family in Eutheria
por: Chang, Ti-Cheng, et al.
Publicado: (2011)

Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells
por: Kewitz, Stefanie, et al.
Publicado: (2013)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases
por: Zhang, Shanxiang, et al.
Publicado: (2015)

EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
por: Şimşek, Cem, et al.
Publicado: (2019)

Intravascular Large B-Cell Lymphoma of the Gallbladder
por: Çetin, Bülent, et al.
Publicado: (2018)

An Unusual Presentation of Systemic B-Cell Lymphoma
por: Joseph, Sharon, et al.
Publicado: (2023)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

PRAME expression and clinical outcome of breast cancer
por: Epping, M T, et al.
Publicado: (2008)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

Extracavitary KSHV-positive Solid Lymphoma: A Large B-cell Lymphoma Within the Spectrum of Primary Effusion Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2013)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma of the Thyroid
por: Ichikawa, Satoshi, et al.
Publicado: (2013)

KIT mutations in primary mediastinal B-cell lymphoma
por: Nagel, P D, et al.
Publicado: (2014)

Transforming B cell lymphoma: A diagnostic dilemma
por: Karadwal, Asha, et al.
Publicado: (2020)

Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group
por: Chihara, Takeshi, et al.
Publicado: (2011)

Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma
por: Zhang, Huilai, et al.
Publicado: (2022)

Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms and B-Cell Non-Hodgkin Lymphoma
por: Joob, Beuy, et al.
Publicado: (2018)

Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case
por: Ittel, A, et al.
Publicado: (2015)

Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
por: Peña, Camila, et al.
Publicado: (2020)

Aberrant Loss of Surface CD3 and TCRγδ Expression in Relapsed Hepatosplenic T-cell Lymphoma
por: Lee, Beomki, et al.
Publicado: (2021)

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2(Prame) complex
por: Zhang, Wenjuan, et al.
Publicado: (2021)

A Case of Cutaneous Diffuse Large B-cell Lymphoma
por: Çetin, Bülent, et al.
Publicado: (2014)

Genetic diversity of newly diagnosed follicular lymphoma
por: Asmann, Y W, et al.
Publicado: (2014)

Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
por: Gajendra, Smeeta, et al.
Publicado: (2015)

Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
por: Lee, Taegeun, et al.
Publicado: (2018)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_af1t6e6lfbj5k0ptpk28u2bq1c